Adam Maeder

Stock Analyst at Piper Sandler

(4.65)
# 1364
Out of 5,456 analysts
146
Total ratings
Success rate
Average return
22 Stocks
Name Action PT Current % Upside Ratings Updated
RBOT Vicarious Surgical
Maintains: Neutral
9 7
6.65 5.26% 8 Aug 13, 2025
INSP Inspire Medical Syst...
Maintains: Overweight
233 150
96.06 56.15% 15 Aug 5, 2025
RMD ResMed
Maintains: Neutral
248 270
293.72 -8.08% 4 Aug 1, 2025
EW Edwards Lifesciences
Maintains: Overweight
83 90
81.82 10% 16 Jul 25, 2025
ISRG Intuitive Surgical
Reiterates: Overweight
575 595
476.16 24.96% 20 Jul 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
18 10
9.28 7.76% 2 Jul 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
4 4
4.23 -5.44% 1 Jun 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
5 4
2.38 68.07% 4 May 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
25 14
13.23 5.82% 3 May 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
133 145
132.56 9.38% 3 Apr 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
6 6
5.84 0.17% 16 Feb 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
52 80
79.97 0.04% 7 Jan 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
20 21
13.58 54.64% 2 May 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
18 20
27.49 -27.25% 6 May 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
290 360
334.75 7.54% 10 Apr 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
7 8
3.4 135.29% 1 Mar 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
15 20
6.43 211.04% 8 Mar 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
75 71
n/a n/a 8 Jan 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
6 5
2.9 72.41% 2 Mar 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
10 18
1.66 984.34% 2 Jan 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
104 99
55.9 77.1% 3 May 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
9 11
10 10% 5 Jun 14, 2021